Stefanie M Bode-Böger Selected Research

Embolic Stroke

1/2019	Plasma Dimethylarginine Levels and Carotid Intima-Media Thickness are related to Atrial Fibrillation in Patients with Embolic Stroke.
1/2012	Endothelial dysfunction of the peripheral vascular bed in the acute phase after ischemic stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefanie M Bode-Böger Research Topics

Disease

9	Infections 12/2021 - 01/2006
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 05/2003
8	Chronic Renal Insufficiency 10/2018 - 01/2002
6	Inflammation (Inflammations) 11/2021 - 05/2006
6	Heart Failure 01/2021 - 07/2010
6	Stroke (Strokes) 01/2021 - 01/2012
6	Critical Illness (Critically Ill) 01/2019 - 01/2006
5	Ischemic Stroke 01/2020 - 11/2012
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 04/2006
5	Renal Insufficiency (Renal Failure) 10/2015 - 01/2002
5	Atherosclerosis 06/2007 - 01/2002
4	Rheumatoid Arthritis 01/2022 - 10/2002
4	Diabetes Mellitus 01/2021 - 05/2004
4	Acute Kidney Injury (Acute Renal Failure) 01/2019 - 01/2006
3	Fibrosis (Cirrhosis) 11/2021 - 05/2006
3	Hypertension (High Blood Pressure) 11/2021 - 04/2005
3	Atrial Fibrillation 12/2019 - 06/2012
3	Carotid Artery Diseases 11/2013 - 03/2007
3	Sepsis (Septicemia) 10/2013 - 06/2010
3	Hypercholesterolemia 08/2007 - 08/2004
2	Chronic Kidney Failure (Chronic Renal Failure) 09/2022 - 04/2005
2	Neoplasms (Cancer) 01/2021 - 04/2009
2	Diabetic Nephropathies (Diabetic Nephropathy) 12/2019 - 11/2017
2	Body Weight (Weight, Body) 01/2019 - 08/2004
2	Embolic Stroke 01/2019 - 01/2012
2	Albuminuria 11/2017 - 05/2006
2	Proteinuria 03/2016 - 08/2005
2	Hypotension (Low Blood Pressure) 12/2012 - 04/2009
2	Congenital Heart Defects (Congenital Heart Defect) 01/2012 - 01/2011
2	Coronary Disease (Coronary Heart Disease) 09/2010 - 05/2009
2	Myocardial Infarction 04/2010 - 03/2009
1	Psoriatic Arthritis 01/2022
1	Vascular Remodeling 11/2021
1	Cardiomegaly (Heart Hypertrophy) 11/2021
1	COVID-19 04/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Venous Thromboembolism 01/2021
1	Vascular Calcification 01/2019
1	Cerebral Hemorrhage 12/2017
1	Brain Injuries (Brain Injury) 12/2017

Drug/Important Bio-Agent (IBA)

25	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 11/2021 - 01/2002
16	Arginine (L-Arginine)FDA Link 01/2021 - 01/2003
12	Nitric Oxide Synthase (NO Synthase)IBA 08/2013 - 01/2002
9	dimethylarginineIBA 01/2019 - 10/2004
9	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2017 - 05/2003
8	CreatinineIBA 01/2021 - 01/2002
8	symmetric dimethylarginineIBA 12/2019 - 11/2012
6	Pharmaceutical PreparationsIBA 01/2022 - 10/2012
6	Biomarkers (Surrogate Marker)IBA 12/2019 - 01/2002
5	HomoarginineIBA 01/2021 - 11/2013
4	Colistin (Coly-Mycin)FDA Link 01/2019 - 10/2013
3	EnzymesIBA 11/2021 - 12/2012
3	Meropenem (Merrem)FDA LinkGeneric 06/2019 - 01/2006
3	Anti-Bacterial Agents (Antibiotics)IBA 06/2019 - 02/2010
3	OrnithineIBA 11/2013 - 08/2007
3	Daptomycin FDA Link 06/2010 - 11/2008
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2020 - 08/2013
2	Streptozocin (Streptozotocin)FDA Link 12/2019 - 11/2017
2	CalciumIBA 01/2019 - 06/2012
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2018 - 11/2012
2	C-Reactive ProteinIBA 01/2018 - 11/2012
2	Inflammation MediatorsIBA 01/2018 - 11/2012
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2018 - 11/2012
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 11/2012
2	Angiopoietin-2IBA 01/2014 - 08/2010
2	pro-brain natriuretic peptide (1-76)IBA 10/2013 - 01/2012
2	Erythropoietin FDA Link 08/2013 - 04/2005
2	NitratesIBA 10/2011 - 08/2004
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2010 - 05/2004
2	CholesterolIBA 08/2004 - 05/2004
1	MidkineIBA 09/2022
1	upadacitinibIBA 01/2022
1	Delayed-Action PreparationsIBA 01/2022
1	Fosfomycin FDA Link 12/2021
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 11/2021
1	ElastinIBA 11/2021
1	Angiotensin IIIBA 11/2021
1	dimethylargininaseIBA 11/2021
1	Chloroquine (Aralen)FDA LinkGeneric 04/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 04/2021
1	AnticoagulantsIBA 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	beta-LactamsIBA 06/2019
1	Carbapenems (Carbapenem Antibiotics)IBA 06/2019
1	methanesulfonic acid (methanesulfonate)IBA 01/2019
1	LipidsIBA 01/2019
1	ProdrugsIBA 01/2019
1	Alkaline PhosphataseIBA 01/2019
1	6-guanidino-2-oxocaproic acidIBA 10/2018
1	IsotopesIBA 10/2018
1	ThrombospondinsIBA 01/2018
1	Metalloproteases (Metalloproteinases)IBA 01/2018
1	von Willebrand FactorIBA 01/2018
1	DisintegrinsIBA 01/2018
1	AlbuminsIBA 11/2017

Therapy/Procedure

11	Therapeutics 01/2018 - 04/2005
2	Renal Dialysis (Hemodialysis) 09/2022 - 01/2006
2	Intermittent Renal Replacement Therapy 12/2021 - 01/2019
2	Hybrid Renal Replacement Therapy 07/2014 - 11/2008
2	Stents 04/2010 - 05/2009